Antitumour Antibiotics by Fox, B. W.
BOOK REVIEWS 489
ing in the literature. After an introductory
chapter listing 7 schema of isolation of the
natural product, structural formulae w%ith
details such as molecular weight, bioactivity
in different tumour systems, melting point
and the organism of origin, with references,
are given. The existence (but not details)
of spectral data are noted. There is a detailed
index to both the substances themselves
(about 400) and 343 references. There is also
a useful appendix on the Cancer Evaluation
System employed by the U.S. National
Cancer Institute, listing the abbreviations
normally used by them.
These two books are timely and provide
a feast of information for the cancer research
worker and the synthetic chemist, as well as
an information and reference source for those
involved in teaching this otherwise complex
aspect of medical treatment.
B. W. Fox
Antitumour Antibiotics. Eds S. K. CARTER,
H. UMEZAWA, J. DoUROS & Y. SAKURAI.
(Recent Results in Cancer Research, Pt.
63) (1978). Berlin, Neew York: Springer-
Verlag. 303 pp. $42.50 net.
This book is a collection of official papers
delivered to the 3rd Symposium held in San
Francisco in May 1977 as part of the joint
US-Japan Agreement on Cancer Research,
and supported by the Northern California
Cancer Program.
The contribution of this U.S.-Japanese co-
operation to antitumour antibiotic develop-
ment has, without doubt, been of very
considerable benefit to the clinical contain-
ment ofmany human tumours. The historical
background and current developments in this
field are very well summarized in this collec-
tion of papers, and fully justify its publica-
tion. Following a short introduction by S. K.
Carter, the chairman of the U.S. Chemo-
therapy subsection of the agreement, 2
informative review papers by medical repre-
sentatives of Japan and the U.S. summarize
the clinical role of antitumour antibiotics in
their respective countries. This is followed by
a historical review of the National Cancer
Institutes Fermentation Development Pro-
gram by J. Douros, listing the interesting
products obtained. A satisfactory aspect of
this paper is the careful attention paid to the
illustration of full structural formulae and
their respective NSC nomenclature coding,
wNNhich makes it a useful reference source. A
selection of antitumour evaluations of single
and combined treatment in a number of
experimental tumours is briefly listed by
J. M. V7enditti and R. K. Johnson, and in
microbial systems by J. P. N. Rosozza. How-
ever, there are clearly problems as to which
assay system is likely to give the greatest
yield of useful antitumour agents, and the
relative importance of different assay sys-
temns available is discussed by L. J. Hanka
and R. H. Bunge and their respective co-
workers. The development and operation of
the Chemotherapy Fermentation Laboratory
at the Frederick Cancer Research Center is
described in some detail by A. F. Langlykke.
The problem of improving detectioin of
potentially useful antitumour agents con-
tinues to provide a rich forum for discussion,
and a review on the criteria employed by a
distinguished practitioner in this field, A.
Goldin, is useful as reference source of new
analogues and of treatment protocols.
A fascinating paper by H. Umezawa sum-
marizes both the theory and the facts behind
the Japanese programme, with special refer-
ence to bleomycin and its analogues. As with
many other papers from this author, there is
a great deal of description of new and in-
teresting biochemical transformations written
in an interesting and thought-provoking
manner.
Y. Koyama's papers on the current status
of chemotherapy for gastric cancer in Japan
outlines the special oncological problems of
that country, as well as the clinical success of
mitomycin C in its management. A U.S. con-
tribution to this study follows with a paper by
P. S. Schein and co-workers. M. A. Friedman
outlines the role and status of bleomycin in
combination with other agents that are used
in the U.S. Its combination with radiation in
Japan is then discussed by T. Miyamoto and
later by N. Yamanaka and co-w-orkers in
experimental systems. The bleomycin pro-
gramme in Japan has produced over 300
analogues. and detailed studies ofantituinour
properties and toxic side-effects have led to
general conclusions about the origin of these
properties within the structure ofthe molecule
itself. A. Matsuda and co-workers review this
extraordinary piece of co-ordinated research
effort. Radioimmunoassay technology applied
to bleomycin has allowed for more detailed
pharmacokinetic studies in man, reviewed by
S. T. Crooke and co-workers.
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Anthracycline analogues, such as adria-
mycin, have been studied in many countries
since its original discovery in Italy, and the
U.S. contribution to this field by R. S.
Benamin reviews the more recent work. The
clinical use ofadriamycin is not as frequent in
Japan as in Europe and the U.S., being re-
placed to some extent by mitomycin C. How-
ever, H. Furue and T. Komita have reviewed
the Japanese application of this agent.
Specializedpapersofmacromomycin aclacino-
mycin and neocarzinostatin also appear.
A paper by Y. Sakurai, apparently out of
context with the main theme of the book,
discusses some of the synthetic analogues of
nitrosoureas, alkylating agents, antimetabo-
lites and platinum complexes under present
study in Japan.
The whole book is a most useful addition to
the library of both students and practitioners
of oncology. As with many such books, how-
ever, the lack of an index is inexcusable. Its
value could have been immensely enhanced
by even the shortest listing, of drug and
tumour data contained within it.
B. W. Fox
Radiobiology for the Radiologist. 2nd
Edn. E. J. HALL (1978). Maryland, U.S.A.:
Harper and Row. 460 pp. £25.00 net.
This is the second edition of an already
highly regarded text. The subjects presented
are wide-ranging, in order to cover material
relevant to Diagnostic Radiology and Nuclear
Medicine, as well as to Radiotherapy. Modifi-
cations in this edition include an expansion of
the section on carcinogenesis and genetic
effects, with a discussion ofrisk versus benefit
which is similar to the ideas embodied in the
new ICRP recommendations. Also, for the
radiotherapist, sections on sensitizers and
hyperthermia have been expanded in the
light of much new information, and the sec-
tions on high LET and human tumour
kinetics have been updated.
On the radiotherapy sections, the reviewer
has a few comments. The mathematical
reason why 37% survival is chosen as a para-
meter for defining the slope of cell-survival
curves is not given, and it could help students
in their understanding. In discussing LD50
endpoints, e.g. for mouse lung, the rather
ambiguous statement that a dose-response
curve is not obtainable may surprise many
radiotherapists who recognize such curves for
the incidence of complications or recurrence.
The rationale for low-dose-rate radiotherapy
includes reoxygenation and overall time, but
the still-controversial facet of a reduced
cellular "oxygen effect" is not mentioned.
The phrase "thermal tolerance" is used here
and widely by others to denote acquired re-
sistance to heat after prior heating. This con-
flicts with the accepted meaning of tolerance
in radiotherapy, and can be a source of con-
fusion.
The new S.I. units are quoted in some
cases as footnotes, but as this volume appears
during the coming-of-age ofS.I. units, a table
of common comparative values would have
been useful. In general, the presentation is
lucid, concise and quantitative. Key words
are emphasized in bold type, and sufficient
examples are given for teaching purposes.
This book is strongly recommended for
students of Radiology and Radiobiology. It
covers the syllabus ofmany teaching courses,
including Diagnostic Radiology for the
Radiological Society of North America.
J. H. HENDRY
Asbestos and Disease. J. J. SELIKOFF &
D. H. K. Lee (1978). New York: Academic
Press. $31.50.
This book has taken a long time to appear.
and many ofus have been apprehensive about
the contents. Now that the waiting period is
over, we are relieved to find that it is a com-
prehensive review of the literature on the
diseases associated with exposure to asbestos
dust. As it has had a long preparation most
ofthe references are about 5 years old, but in
places it has been brought up to date by
addenda or with current reports from the
Mount Sinai School ofMedicine in New York.
Further, there is a loose page labelled
"Comments, Clarifications and Errata", which
keeps getting mislaid.
The literature has been studied in a most
thorough manner, nearly a third of the 3000
references being quoted. From many, the
highlights have been used verbatim, and a
large number of tables from acknowledged
sources appear. The authors have covered
most of the hard-fought controversial facets
of the story and have, on the whole, been
impartial. The major exception to this is the
failure to quote the full evidence implicating